Intradermal immunization improves protective efficacy of a novel TB vaccine candidate
- 26 March 2009
- Vol. 27 (23), 3063-3071
- https://doi.org/10.1016/j.vaccine.2009.03.018
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Characterisation of epidermal lipid composition and skin morphology of animal skin ex vivoEuropean Journal of Pharmaceutics and Biopharmaceutics, 2009
- Immunization with a Toll-Like Receptor 7 and/or 8 Agonist Vaccine Adjuvant Increases Protective Immunity againstLeishmania majorin BALB/c MiceInfection and Immunity, 2008
- Agonists of Toll-Like Receptors 3, 4, 7, and 9 Are Candidates for Use as Adjuvants in an Outer Membrane Vaccine againstNeisseria meningitidisSerogroup BInfection and Immunity, 2007
- Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania majorNature Medicine, 2007
- A Toll-Like Receptor-2-Directed Fusion Protein Vaccine against TuberculosisClinical and Vaccine Immunology, 2007
- Translational Mini-Review Series on Vaccines:
Development and evaluation of improved vaccines against tuberculosisClinical and Experimental Immunology, 2007
- NOD2 and Toll-Like Receptors Are Nonredundant Recognition Systems of Mycobacterium tuberculosisPLoS Pathogens, 2005
- Toll-like receptor control of the adaptive immune responsesNature Immunology, 2004
- Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing AgentNew England Journal of Medicine, 2001
- The Imidazoquinolines, Imiquimod and R-848, Induce Functional, but Not Phenotypic, Maturation of Human Epidermal Langerhans' CellsClinical Immunology, 2000